Insight

New study on overdiagnosis of prostate cancer in Europe – IARC

Photo taken from IARC/LinkedIn

Sep 10, 2024, 01:15

New study on overdiagnosis of prostate cancer in Europe – IARC

IARC – International Agency for Research on Cancer shared the following on LinkedIn:

“A paper on overdiagnosis of prostate cancer in Europe focuses on epidemiological characteristics of prostate cancer in Europe, and contrasts between heterogeneous incidence trends and more uniform decreases in mortality from prostate cancer.

Study published in The BMJ.”

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study

Authors: Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvale, Diego Serraino, Valentina Lorenzoni, Anssi Auvinen, Luigino Dal Maso

New study on overdiagnosis of prostate cancer in Europe - IARC

Read further.
Source: IARC – International Agency for Research on Cancer/LinkedIn

Anssi Auvinen cancer Diego Serraino epidemiology europe Freddie Bray IARC International Agency for Research on Cancer Luigino Dal Maso Mengmeng Li OncoDaily Oncology overdiagnosis prostate cancer Rune Kvale Salvatore Vaccarella The BMJ Valentina Lorenzoni

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage